Search
Search Results
-
Analysis of ocular fluid in patients with ranibizumab-recalcitrant neovascular age-related macular degeneration who have serum anti-ranibizumab antibodies
PurposeTo evaluate whether anti-drug antibodies (ADAs) are present in the ocular fluid of patients with ranibizumab-recalcitrant neovascular...
-
Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study
IntroductionThe study aimed to evaluate comparability in terms of efficacy, safety and immunogenicity of Sun’s ranibizumab biosimilar with reference...
-
Comparison of anatomical and functional outcomes of treating myopic choroidal neovascularization with bevacizumab or ranibizumab
PurposeTo compare results of treatment with bevacizumab and ranibizumab injections in myopic choroidal neovascularization (mCNV).
Methods ...
-
Comparison of clinical effectiveness of conbercept and ranibizumab for treating retinopathy of prematurity: a meta-analysis
BackgoundConbercept and ranibizumab have been used to treat retinopathy of prematurity (ROP). However, the clinical effectiveness of conbercept and...
-
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
PurposeTo determine the safety and efficacy of adding topical bromfenac 0.09% in the treatment of diabetic macular edema.
MethodsSeventy patients...
-
Efficacy, Safety, and Treatment Burden of Aflibercept 2 mg and Ranibizumab in Retinal Vein Occlusion: A Systematic Review and Meta-analysis
IntroductionThis systematic review and meta-analysis aimed to provide an updated evidence base for clinical decision-making by comparing the efficacy...
-
Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study
PurposeTo compare the visual and anatomic outcomes of intravitreal ranibizumab versus aflibercept in patients with diabetic macular edema (DME) in a...
-
Comparison of post-treatment recurrence between ranibizumab injection and laser photocoagulation for type 1 retinopathy of prematurity
ObjectiveTo compare post-treatment recurrence between ranibizumab injection and l aser photocoagulation (LP) for type 1 retinopathy of prematurity...
-
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
IntroductionTo analyze the efficacy of biosimilar ranibizumab compared to innovator ranibizumab and bevacizumab.
MethodsWe retrospectively analyzed...
-
Refractive status and retinal morphology in children with a history of intravitreal ranibizumab for retinopathy of prematurity
This study investigated the characteristics of refractive status, visual acuity, and retinal morphology in children with a history of receiving...
